453: Implementing a Process to Update Referring Physicians Regarding Unrelated Donor Search Activity  by Wehde, M.A.
160 Poster Session IInon-oncology patients and preceptors; and the BMT staff’s discom-
fort level in mastering ICU skills. The Clinical Nurse Specialist
(CNS) developed a training program that included BMT specific
critical care education and clinical training in a human simulator
laboratory. Components of the class included: pulmonary physiol-
ogy and ventilator basics with trouble shooting strategies presented
by a respiratory therapist; a critical care policy and procedure game;
review of BMT specific complications that lead to the need for in-
tensive care such as sepsis and intracranial hemorrhage. These com-
plications were then presented in the human simulator laboratory.
The initial class was a preceptor training program designed for
the small group of nurses who currently cared for the BMT ICU pa-
tients. This group was educated on precepting skills for experienced
nurses. The second class, designed for the staff who has attended di-
dactic ICU training, has been implemented as well. Evaluations of
the program were positive and rated the simulator laboratory as
an experience that all staff should have. A plan has been established
to send the remaining staff though this training program. Addition-
ally, each nurse will be paired with a BMT ICU preceptor for the
clinical experience needed to gain competence to care for BMT
ICU patients. Continual ICU education is now a part of yearly skills
days and incorporated into the overall education plan for all unit
staff.451
DENIALS AND APPEALS PROCESSING MADE MAJOR IMPACT IN PATIENT
ACCESSING STEM CELL TRANSPLANTATION
Hontiveros, R.L., Champlin, R.E. U.T. MD Anderson Cancer Center,
Houston, TX.
Denials of coverage by insurance carriers are major problems for
patients requiring stem cell transplantation (SCT). Submitting
treatment plans for SCT to the third party payors may result to de-
nials and potential delay of treatments for patients. The large vol-
ume of denied SCT services plus the complexity of insurance
appeal process became an enormous hurdle for patients and cancer
centers, clinically and financially.
In one of the largest SCT centers in the country, appeals of de-
nied services were previously handled by the patient’s Patient Access
Coordinator (PtAC). Several of these denials were upheld after sev-
eral appeals. Through team consensus, it was deemed necessary to
have one PtAC to concentrate on handling all the appeals for the de-
partment in May 2004. The common reasons for denials were mon-
itored and recorded. The reasons for denials include: investigational
protocols - 88%, deemed not a covered benefit - 5%, phase of pro-
tocol not covered - 2%, and the other reasons like: insurance criteria
not met, out of network, lack of clinical information, not covered by
plan language, deemed clinical trial are all less than 1% of cases.
The attending physicians/multidisciplinary team were educated
on these reasons and how to avoid denials. If denials are still re-
ceived for SCT services, these steps were taken: instructed patient
to request assistance from case manager/employer to overturn de-
nial, verbal appeal by PtAC, peer-to-peer review between MD
and medical reviewer, appeal letter/supporting documents sent,
switch treatment plan to SOC from a clinical trial, and vigorous ap-
peal/negotiation during appeal panel session.
Staggering results showed overturned denial of 50% - April 2004-
March 2005, 53% - April 2005 – March 2006, and 52% - April 2006
– March 2007 respectively. This process truly relieves patients from
complicated appeal process and enables other PtAC’s to focus on
other duties.452
PLASMA B-TYPE NATRIURETIC PEPTIDE: ITS ROLE IN PEDIATRIC HE-
MATOPOIETIC STEM CELL TRANSPLANTATION AND IMPLICATIONS
FOR NURSES
Bertin,H.D.1, Koontz, S.E.2, Petropoulos, D.3,Worth, L.L.3, Lee, D.A.3,
Cooper, L.J.N.3. 1Children’s Cancer Hospital at The University of Texas
M.D. Anderson Cancer Center, Houston, TX; 2Children’s Cancer Hospi-
tal at The University of Texas M.D. Anderson Cancer Center, Houston,TX; 3Children’s Cancer Hospital at The University of Texas M.D. An-
derson Cancer Center, Houston, TX.
The process of and procedures surrounding hematopoietic stem
cell transplantation (HSCT) can produce significant and acute mor-
bidity in pediatric patients. One system at risk for compromise fol-
lowing transplantation is the cardiovascular system, specifically
injury to the myocardium. Damage to the heart can occur through
a variety of mechanisms and certain patient populations may be at
higher risk for sequelae from cardiovascular injury. Judicious mon-
itoring of patients and early recognition of impending problems are
important to minimize complications following HSCT and the
need for additional medical interventions. However, methods to di-
agnose early acute complications, such as cardiac catheterization,
are often not practical in pediatric HSCT recipients. Reliance on
monitoring heart rate and blood pressure to signal impending car-
diovascular problems are non-specific and may not lead to early in-
dications of heart-related adverse events. Therefore, we have
developed a method to complement serial monitoring of vital signs
to identify cardiac compromise by longitudinal measurements of
plasma B-type natriuretic peptide (pBNP).
Recognizing that the role of this peptide is not fully understood in
patients undergoing HSCT, the basic understanding of pBNP by
our nursing staff was limited. Therefore, the need for educating
nurses involved in the care of HSCT patients and monitoring of pa-
tients’ cardiac function was identified. A self-assessment tool has
been created to measure nurses’ understanding of cardiac complica-
tions such as congestive heart failure (CHF) and the clinical utility
of pBNP in this setting. Nurses assigned to the care of HCST pa-
tients have been asked to complete this self-assessment tool.
Upon completion of the pre-test, nurses participate in a learning
module which aims to enhance their understanding of cardiac ad-
verse events, the role of pBNP in this patient group and relevant
clinical interventions. Improvement and gains in knowledge are
measured through the administration of a post-test. We will present
staff educational materials and the results of pre- and post-test
self-assessment examinations. Additionally, nursing roles and
responsibilities relating to identifying and caring for high-risk pedi-
atric patients will be summarized. This use of pre- and post-assess-
ment tools demonstrates how nurses can be taught to improve their
vigilance and management of cardiac toxicities in children undergo-
ing HSCT.453
IMPLEMENTING A PROCESS TO UPDATE REFERRING PHYSICIANS RE-
GARDING UNRELATED DONOR SEARCH ACTIVITY
Wehde, M.A. Siteman Cancer Center, St. Louis, MO.
Background: The process of identifying a suitable unrelated do-
nor or cord blood unit can take days to weeks. During the search
process, ongoing communication between the transplant center
and referring physician is crucial to a successful unrelated donor
transplant. The unrelated donor search team at Siteman Cancer
Center identified a need to improve the process of updating refer-
ring physicians regarding their patient’s donor search and took steps
to implement a well defined process. Objectives: As a transplant
center with a large volume of unrelated donor search activity, the
donor search team identified the following key items for a successful
process: the process must require a limited amount of time to com-
plete, the information provided must be concise yet informative,
and the language used must be similar to that found in resources
from the National Marrow Donor Program to avoid misunder-
standing of information provided. Method: The unrelated donor
search team divided the search process into three phases: prelimi-
nary, formal and donor selection/workup.
A one page form was developed for each phase along with guide-
lines regarding the frequency of completing the update.
1) Preliminary phase: The update form contains a short descrip-
tion of a preliminary search, the number of potential donors and
recommendation regarding a donor search. This is completed at
the time of the preliminary search.
2) Formal phase: The form contains a description of a formal
search and a summary detailing the progress of identifying a donor
Poster Session II 161or cord blood unit. The form is completed when a formal search is
initiated, then every 2 weeks.
3) Donor selection and workup phase: The form contains a de-
scription of the donor workup process, details of the selected donor,
and transplant plan. This is completed at the time the donor workup
request is submitted and when a transplant date has been estab-
lished.
Once the update form is completed by the search coordinator, it
is faxed to the referring physician’s office. Each form contains the
name and contact number of the coordinator managing the search
if needed. Results: An informal survey of referring physicias and
nursing staff demonstrates a positive response to the update format.
Based on this feedback, a user friendly and well defined process to
update referring physicians regarding the progress of identifying
a suitably matched unrelated donor or cord blood unit has been suc-
cessfully implemented at a large volume transplant center.454
DOUBLE CORD BLOOD TRANSPLANTS IN PEDIATRIC PATIENTS: IMPLI-
CATIONS FOR NURSES – WHAT IS ALL THE HYPE ABOUT?
Carstens, K.A.1, Ortiz, J.M.1, Koontz, S.E.2, Worth, L.L.3,
Petropoulos, D.3, Lee, D.A.3, de Lima, M.J.4, Shpall, E.4,
Cooper, L.J.N.3. 1Children’s Cancer Hospital at The University of Texas
M. D. Anderson Cancer Center, Houston, TX; 2Children’s Cancer Hos-
pital at TheUniversity of TexasM.D. Anderson Cancer Center, Houston,
TX; 3Children’s Cancer Hospital at The University of Texas M. D. An-
derson Cancer Center, Houston, TX; 4The University of Texas MD An-
derson Cancer Center, Houston, TX.
In recent years, numerous advances in the field of Stem Cell
Transplantation and Cellular Therapy (SCTCT) have been made
in treating a variety of cancers and nonmalignant conditions in chil-
dren. One such novel treatment approach in this patient population
has been the infusion of two cord blood units following condition-
ing with chemotherapy and immune modulating drugs. With this
advancement has come the need to educate healthcare providers re-
sponsible for the care of patients undergoing this form of transplan-
tation in order to enhance their patient care skills.
Nurses have played an indispensable role in caring for these pa-
tients during all phases of the transplantation process. From the ini-
tial patient work-up to the time a patient is transferred back to their
home clinic, a variety of nurses have several roles and responsibili-
ties which allow for seamless care and optimal patient outcomes. Al-
though many policies and procedures related to double cord blood
transplants parallel those associated with other types of transplants,
there are some unique challenges and opportunities in this setting of
which nurses should be aware.
Using patient examples we will highlight the key points relating
to nursing care of pediatric patients undergoing double cord blood
transplants. Advantages and disadvantages of double cord blood
transplants will be summarized and compared to other methods
of transplantation. Additionally, we will present practice standards
developed specifically to address some of the unique clinical chal-
lenges seen in these patients during the post-transplant period. Fol-
lowing our presentation, nurses are expected to have a broader
understanding of the biology and patient care needs of double
cord blood recipients as well as the potential for reductions in hos-
pitalization duration, overall costs and morbidity during the post-
engraftment period.455
A PRACTICAL TOOL FOR NEWLY SPECIALIZING NURSES
Hogan, M.B. Barnes-Jewish Hospital, St. Louis, MO.
Equipped with three months of training and a voluminous binder,
new nurses to BMT traditionally have reported approximately two
years of trial and error in their practice before feeling confident
about their care. A vast specialized knowledge is required immedi-
ately for new nurses’ practice, particularly night nurses who are re-
sponsible for treating labs drawn by day shift—usually according to
standing orders, contacting physicians to adjust treatments based ondrug levels, checking chemotherapy orders and giving first doses,
and reviewing 24 hours worth of orders for accuracy and consis-
tency to the computer system.
To address new nurses’ frustrations, a critical thinking tool was
developed on the standard orders. The goal was two–fold: nurses
learn the standing orders and bridge gaps between their nursing
knowledge bases, specifics to BMT, considerations for each order
from rationale and expected effects to observed side effects and con-
traindications for which to assess before carrying out orders. Some
orders lay out algorithms, like those found on crash carts. Precep-
tors spend approximately one week working in–depth on each
page with the new nurses and review the entirety numerous times
throughout orientation.
Four new nurses were given this teaching tool; two of the nurses
were new graduates, one had a year nursing experience, and one is in
orientation currently. Anecdotal evidence has been compelling. The
three nurses who successfully completed orientation reported the
tool was the first, easiest reference they sought before contacting
the on–call physician or even questioning another nurse, and they
pocketed the tool during their shifts. Each nurse discovered addi-
tional questions, for instance, the implications of radiological tests
and often–ordered cardiac enzymes. Therefore, the tool is con-
stantly changing to reflect their needs and similar conjuntive tools
are being developed, one entitled ‘‘Drips.’’ Additionally, ten veteran
nurses requested copies to improve their practice.456
NURSING GUIDELINES FOR THE MANAGEMENT OF STEM CELL TRANS-
PLANT PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
Babino, E.M.G., Estrella, J.M.E. UTMDCancer Center, Houston, TX.
Topic/Background: : Stem Cell Transplant (SCT) patients are
faced with rigorous challenges throughout the transplant process
as a result of chemotherapy regimen, prolonged state of neutropenia
and complications brought about by the transplant itself. One com-
plication that has been observed after SCT is Thrombotic Throm-
bocytopenic Purpura (TTP), also known as Hemolytic Uremic
Syndrome (HUS). Purpose: The purpose of this abstract to de-
velop nursing guidelines in the care of SCT patients with TTP/
HUS. The tool will present nursing assessment, monitoring of
symptoms, diagnostic exams, interventions, management and eval-
uation of treatment. Discussion/Intervention: Reports suggest
about 13% of SCT patients may develop TTP/HUS and those
with prolonged thrombocytopenia, infections, and graft-versus-
host-disease (GVHD) are placed at a higher risk (Sawant & Rajad-
hyaksha, 2005). TTP/HUS is a complex syndrome of vascular
endothelial injury and platelet thrombus formation within micro-
vasculature that may lead to ischemia of the brain, kidney or heart,
and may even result to death. The SCT nurse plays an important
role in the recovery of patients in the acute care setting through clin-
ical knowledge of the disease process, identification of symptoms,
critical laboratory values, timely interventions and efficient man-
agement of complications. Implication to Nursing: Due to the
complexity of care of SCT patients and the seriousness of TTP/
HUS as a post transplant complication, communication and collab-
oration between the bedside nurse and the primary team are highly
essential. In addition to conventional supportive treatments and
monitoring of pertinent laboratory values, timing and immediate
initiation of plasma exchange is crucial. Evaluation: This poster
presentation will include a case study of a patient manifesting the
classic symptoms of TTP/HUS and the nursing guidelines to assist
the SCT nurse in providing the appropriate care.457
ZAP THAT ENERGY BACK: ENGAGING THE STEM CELL TRANSPLANT PA-
TIENT IN TERTIARY ACTIVITIES
Estrella, J.M.E., Granada, M.L.A. UT MD Anderson Cancer Center,
Houston, TX.
Topic/Background: Myeloablative and non-myeloablative regi-
mens have led to increased patient eligibility for Stem Cell
